CompanyOverview|NASDAQ:TEM] Tempus AI (NASDAQ: TEM) is an emerging AI player in the healthcare field with a robust outlook ...

Tempus AI's Q4 financials were slightly below expectations but aligned with preliminary results, presenting a buying ...

DeepSeek is a stark reminder about the importance of strategic durability, and not just growth or growth potential, to a ...

We recently published a list of 10 AI Stocks on Analysts’ Radar As AI Spending Grows. In this article, we are going to take a ...

Loop Capital raised the firm’s price target on Tempus AI (TEM) to $74 from $52 and keeps a Buy rating on the shares. The company’s Q4 results were ...

Tempus posted a fourth-quarter adjusted net loss of $0.18 per share, $0.02 more per share than estimates by analysts surveyed by Visible Alpha. Revenue jumped 36% year-over-year to $200.7 million, but ...

Tempus AI (TEM) stock dropped 19% Tuesday, the day after the company released a Q4 earnings report that missed Street estimates and its 2025 financial forecast. Read more here.

At this time, I would like to welcome everyone to the Tempus fourth-quarter 2024 financial results conference call. Thank you, Jason. Good afternoon and welcome to Tempus fourth-quarter 2024 ...

Despite filing a fourth-quarter and yearend 2024 earnings report that the CEO described as "fantastic" yesterday afternoon, ...

The shift follows the DeepSeek breakthrough that showed it’s possible to reduce the amount of resources needed to run large ...

Tempus AI (TEM) plunged Tuesday as its quarterly revenues missed expectations, days after insiders were reported as offloading the stock in big ...

EST Tempus AI (TEM) files to sell 4.84M shares of Class A common stock for holdersDiscover the Best Stocks and Maximize Your Portfolio: ...